O, K., JS, P., CC, W., OW, F., E, H., E, B., & D, R. (2025). A case report of total epidermal necrosis following mirvetuximab soravtansine extravasation. Gynecologic oncology reports, 62, 101991. https://doi.org/10.1016/j.gore.2025.101991
Chicago Style (17th ed.) CitationO, Krivenko, Powers JS, Wang CC, Foley OW, Hinchcliff E, Barber E, and Roque D. "A Case Report of Total Epidermal Necrosis Following Mirvetuximab Soravtansine Extravasation." Gynecologic Oncology Reports 62 (2025): 101991. https://doi.org/10.1016/j.gore.2025.101991.
MLA (9th ed.) CitationO, Krivenko, et al. "A Case Report of Total Epidermal Necrosis Following Mirvetuximab Soravtansine Extravasation." Gynecologic Oncology Reports, vol. 62, 2025, p. 101991, https://doi.org/10.1016/j.gore.2025.101991.